These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Lowered ghrelin levels in acromegaly—normalization after treatment]. Kozakowski J, Rabijewski M, Zgliczyński W. Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203 [Abstract] [Full Text] [Related]
4. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. Freda PU, Post KD, Powell JS, Wardlaw SL. J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451 [Abstract] [Full Text] [Related]
5. Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments. Ronchi CL, Giavoli C, Ferrante E, Verrua E, Bergamaschi S, Ferrari DI, Corbetta S, Montefusco L, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P. Eur J Endocrinol; 2009 Jul; 161(1):37-42. PubMed ID: 19351744 [Abstract] [Full Text] [Related]
8. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity. Elias PC, Lugao HB, Pereira MC, Machado HR, Castro Md, Moreira AC. Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623 [Abstract] [Full Text] [Related]
9. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. Serri O, Beauregard C, Hardy J. J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients. Charalampaki P, Hildebrandt G, Schaeffer HJ, Schönau E, Klug N. Exp Clin Endocrinol Diabetes; 1998 Feb; 106(2):130-4. PubMed ID: 9628244 [Abstract] [Full Text] [Related]
12. Are there alternative tests for diagnosis of acromegaly? Popovic V. J Endocrinol Invest; 2005 Feb; 28(11 Suppl International):73-4. PubMed ID: 16625850 [Abstract] [Full Text] [Related]
13. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency. Giavoli C, Profka E, Verrua E, Ronchi CL, Ferrante E, Bergamaschi S, Sala E, Malchiodi E, Lania AG, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P. J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173 [Abstract] [Full Text] [Related]
15. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE. J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596 [Abstract] [Full Text] [Related]
18. Dynamic tests and basal values for defining active acromegaly. Tzanela M. Neuroendocrinology; 2006 Apr; 83(3-4):200-4. PubMed ID: 17047383 [Abstract] [Full Text] [Related]
19. Plasma levels of total and active ghrelin in acromegaly and growth hormone deficiency. Jarkovská Z, Rosická M, Marek J, Hána V, Weiss V, Justová V, Lacinová Z, Haluzík M, Krsek M. Physiol Res; 2006 Apr; 55(2):175-181. PubMed ID: 15910166 [Abstract] [Full Text] [Related]
20. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3. Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A. J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491 [Abstract] [Full Text] [Related] Page: [Next] [New Search]